1832 Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.54M | Sell |
124,314
-40,453
| -25% | -$2.36M | 0.01% | 390 |
|
|
2025
Q4 | $8.89M | Buy |
164,767
+78,987
| +92% | +$3.8M | 0.01% | 376 |
|
|
2025
Q3 | $3.87M | Sell |
85,780
-5,865
| -6% | -$274K | ﹤0.01% | 398 |
|
|
2025
Q2 | $4.24M | Buy |
+91,645
| New | +$4.5M | ﹤0.01% | 385 |
|
|
2024
Q3 | – | Sell |
-1,000
| Closed | -$41.5K | – | 700 |
|
|
2024
Q2 | $41.5K | Sell |
1,000
-73,659
| -99% | -$3.3M | ﹤0.01% | 713 |
|
|
2024
Q1 | $4.05M | Sell |
74,659
-52
| -0.1% | -$2.65K | ﹤0.01% | 402 |
|
|
2023
Q4 | $3.83M | Buy |
74,711
+16,005
| +27% | +$840K | 0.01% | 402 |
|
|
2023
Q3 | $3.41M | Buy |
58,706
+6,448
| +12% | +$395K | ﹤0.01% | 413 |
|
|
2023
Q2 | $3.34M | Sell |
52,258
-642
| -1% | -$43K | ﹤0.01% | 422 |
|
|
2023
Q1 | $3.67M | Buy |
52,900
+4,401
| +9% | +$310K | 0.01% | 434 |
|
|
2022
Q4 | $3.49M | Sell |
48,499
-10,195
| -17% | -$769K | 0.01% | 456 |
|
|
2022
Q3 | $4.17M | Buy |
58,694
+11,519
| +24% | +$836K | 0.01% | 436 |
|
|
2022
Q2 | $3.63M | Buy |
47,175
+43,455
| +1,168% | +$3.31M | 0.01% | 448 |
|
|
2022
Q1 | $269K | Buy |
3,720
+3,400
| +1,063% | +$228K | ﹤0.01% | 697 |
|
|
2021
Q4 | $20K | Sell |
320
-16,112
| -98% | -$945K | ﹤0.01% | 628 |
|
|
2021
Q3 | $1M | Buy |
16,432
+16,062
| +4,341% | +$1.06M | ﹤0.01% | 487 |
|
|
2021
Q2 | $25K | Sell |
370
-248,794
| -100% | -$16.2M | ﹤0.01% | 654 |
|
|
2021
Q1 | $15.7M | Sell |
249,164
-340,424
| -58% | -$21.2M | 0.03% | 257 |
|
|
2020
Q4 | $36.5M | Buy |
589,588
+96,620
| +20% | +$5.94M | 0.09% | 188 |
|
|
2020
Q3 | $29.6M | Buy |
492,968
+28,855
| +6% | +$1.74M | 0.08% | 184 |
|
|
2020
Q2 | $26.9M | Buy |
464,113
+189,760
| +69% | +$11.4M | 0.08% | 167 |
|
|
2020
Q1 | $14.9M | Buy |
274,353
+124,935
| +84% | +$7.64M | 0.05% | 202 |
|
|
2019
Q4 | $9.46M | Buy |
149,418
+12,087
| +9% | +$692K | 0.03% | 234 |
|
|
2019
Q3 | $6.79M | Buy |
137,331
+73,700
| +116% | +$3.46M | 0.02% | 265 |
|
|
2019
Q2 | $2.79M | Buy |
63,631
+32,500
| +104% | +$1.51M | 0.01% | 376 |
|
|
2019
Q1 | $1.47M | Buy |
31,131
+30,531
| +5,089% | +$1.52M | 0.01% | 368 |
|
|
2018
Q4 | $31K | Hold |
600
| – | – | ﹤0.01% | 508 |
|
|
2018
Q3 | $37K | Sell |
600
-22,301
| -97% | -$1.32M | ﹤0.01% | 553 |
|
|
2018
Q2 | $1.17M | Buy |
22,901
+22,301
| +3,717% | +$1.2M | ﹤0.01% | 423 |
|
|
2018
Q1 | $38K | Sell |
600
-25,481
| -98% | -$1.64M | ﹤0.01% | 544 |
|
|
2017
Q4 | $1.54M | Buy |
26,081
+15,926
| +157% | +$996K | 0.01% | 395 |
|
|
2017
Q3 | $629K | Buy |
+10,155
| New | +$593K | ﹤0.01% | 455 |
|
|
2017
Q1 | – | Sell |
-824,728
| Closed | -$49.9M | – | 706 |
|
|
2016
Q4 | $49.9M | Buy |
824,728
+94,928
| +13% | +$5.19M | 0.08% | 204 |
|
|
2016
Q3 | $39.3M | Sell |
729,800
-267,750
| -27% | -$17.2M | 0.15% | 140 |
|
|
2016
Q2 | $73.9M | Buy |
997,550
+994,484
| +32,436% | +$70.3M | 0.29% | 87 |
|
|
2016
Q1 | $311K | Buy |
3,066
+22
| +0.7% | +$1.39K | ﹤0.01% | 443 |
|
|
2015
Q4 | $212K | Buy |
3,044
+94
| +3% | +$6.21K | ﹤0.01% | 453 |
|
|
2015
Q3 | $175K | Sell |
2,950
-525
| -15% | -$33.3K | ﹤0.01% | 452 |
|
|
2015
Q2 | $231K | Buy |
3,475
+3,225
| +1,290% | +$213K | ﹤0.01% | 484 |
|
|
2015
Q1 | $16K | Sell |
250
-325,750
| -100% | -$20.4M | ﹤0.01% | 534 |
|
|
2014
Q4 | $19.2M | Buy |
326,000
+57,900
| +22% | +$3.27M | 0.06% | 212 |
|
|
2014
Q3 | $13.7M | Sell |
268,100
-2,200
| -0.8% | -$110K | 0.04% | 254 |
|
|
2014
Q2 | $13.1M | Sell |
270,300
-25,700
| -9% | -$1.27M | 0.04% | 269 |
|
|
2014
Q1 | $15.4M | Buy |
+296,000
| New | +$15.8M | 0.05% | 229 |
|
Other funds holding BMY
VCM
VPM
1832 Asset Management's BMY Position: Q1 2026 in Review
1832 Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 25% in Q1 2026, selling an estimated $2.36M and leaving 124,314 shares worth $7.54M. The position accounts for 0.01% of the portfolio, ranked #390.
1832 Asset Management first reported a position in BMY in Q1 2014 and has held it in 44 quarters since. The position peaked at $73.9M in Q2 2016. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- 1832 Asset Management held 124,314 shares of Bristol-Myers Squibb worth $7.54M as of Q1 2026.
- 1832 Asset Management sold 40,453 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.36M.
- Bristol-Myers Squibb made up 0.01% of 1832 Asset Management's portfolio in Q1 2026, its #390 holding.
- 1832 Asset Management first reported a position in Bristol-Myers Squibb in Q1 2014 and has held it in 44 quarters since.
- 1832 Asset Management's Bristol-Myers Squibb position peaked at $73.9M in Q2 2016.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on 1832 Asset Management's 13F filing for Q1 2026, filed 14 May 2026.